Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate–mediated chromatin modifications in sickle cell disease
C Xi, J Pang, W Zhi, CSS Chang… - Blood, The Journal …, 2023 - ashpublications.org
Sickle cell disease (SCD) is a chronic hemolytic and systemic hypoxia condition with
constant oxidative stress and significant metabolic alterations. However, little is known about …
constant oxidative stress and significant metabolic alterations. However, little is known about …
Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate–mediated chromatin modifications in sickle cell disease
C Xi, J Pang, W Zhi, CSS Chang… - …, 2023 - augusta.elsevierpure.com
Sickle cell disease (SCD) is a chronic hemolytic and systemic hypoxia condition with
constant oxidative stress and significant metabolic alterations. However, little is known about …
constant oxidative stress and significant metabolic alterations. However, little is known about …
Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease
C Xi, J Pang, W Zhi, CSS Chang… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Sickle cell disease (SCD) is a chronic hemolytic and systemic hypoxia condition with
constant oxidative stress and significant metabolic alterations. However, little is known about …
constant oxidative stress and significant metabolic alterations. However, little is known about …
[HTML][HTML] Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate–mediated chromatin modifications in sickle cell disease
C Xi, J Pang, W Zhi, CSS Chang, U Siddaramappa… - Blood, 2023 - Elsevier
Sickle cell disease (SCD) is a chronic hemolytic and systemic hypoxia condition with
constant oxidative stress and significant metabolic alterations. However, little is known about …
constant oxidative stress and significant metabolic alterations. However, little is known about …